Vaccines 2011-15: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
The high growth rates and successful launch of several products recently have kept interest in the global vaccine market high. The global market for vaccines experienced strong growth through 2010 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions.
Kalorama Information has been closely following vaccine markets and has instituted a yearly market research report schedule since 2003 in order to keep up with fast-moving developments. Our latest comprehensive update, Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, examines the market for vaccines used in humans for various diseases. This state-of-the-industry report is a must-have for any executive who wants to stay on top of a rapidly changing market and see what’s expected down the road based on analysis of major company pipelines.
The report covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable.
Trends discussed in this report include the introduction of needle-free systems and the production of vaccines, as well as product safety, supply shortages, and the use of vaccines to prevent pandemics and address bioterrorism, DNA vaccinations, and innovations in vaccine delivery systems. News and reports of vaccine-related illness tend to exacerbate the public’s fears and result in higher rates of non-immunization, another issue which is discussed in this edition of the report.
Included in this report are current market size and forecast for the following vaccines:
- Other Pediatric
- Cervical Cancer
- Travel; DT; Misc.
Kalorama has expanded the global perspective of this report in this edition, including estimates of vaccine sales (pediatric and adult segments) in the following regions:
- Rest of North Amer.
- South America
- Rest of World
- AlphaVax, Inc.
- Bavarian Nordic A/S
- Baxter Healthcare
- Bharat Biotech
- Celldex Therapeutics
- Crucell / Johnson and Johnson
- Emergent biosolutions
- Merck & Co. Inc
- Nabi Biopharmaceuticals
- Sanofi Pasteur
Revenue estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2005 to 2009 period and forecasts are provided through 2014. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants’ point of view and assess trends... these form the basis of the forecasting and competitive analysis.
All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.